Bo Wei

546 total citations · 1 hit paper
20 papers, 263 citations indexed

About

Bo Wei is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bo Wei has authored 20 papers receiving a total of 263 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Bo Wei's work include Cancer-related molecular mechanisms research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Circular RNAs in diseases (3 papers). Bo Wei is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Circular RNAs in diseases (3 papers). Bo Wei collaborates with scholars based in China, United States and Philippines. Bo Wei's co-authors include Philip L. Lorenzi, Iqbal Mahmud, Shengxin Huang, Dongbing Ding, Jiannan Ren, Rongpu Liang, Masha V. Poyurovsky, Amber D. Horbath, Gengjia Chen and Kellen Olszewski and has published in prestigious journals such as Nature Communications, Gastroenterology and Journal of Controlled Release.

In The Last Decade

Bo Wei

16 papers receiving 260 citations

Hit Papers

Cell cycle arrest induces lipid droplet formation and con... 2024 2026 2025 2024 20 40 60

Peers

Bo Wei
Comparison fields: 5 of 50
  • Molecular Biology 158
  • Cancer Research 114
  • Pulmonary and Respiratory Medicine 71
  • Biomedical Engineering 33
  • Oncology 32
Songtao Cheng China
Qiu Peng China
Bihan Xia China
Yiran Yao China
Sushmaa Chandralekha Selvakumar India
Ming Xia China
Elif Kadife Australia
Songtao Cheng China View profile →
Citations per field, relative to Bo Wei
Bo Wei · 1×
Citations per year, relative to Bo Wei
Bo Wei · 1×

Countries citing papers authored by Bo Wei

Since Specialization
Citations

This map shows the geographic impact of Bo Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Wei more than expected).

Fields of papers citing papers by Bo Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Wei. The network helps show where Bo Wei may publish in the future.

Co-authorship network of co-authors of Bo Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Wei. A scholar is included among the top collaborators of Bo Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Wei. Bo Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 5
2 0
3 0
4 0
5 5
6 0
7 3
8
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance breakdown →
65
9 6
10 10
11 4
12 5
13 36
14 42
15 10
16 7
17 7
18 26
19 5
20 27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026